Skip to main content
OpenTrials
Completed

NCT Number: NCT04417777

Genetic Study of the Dilatations of the Idiopathic Bronchi in French Polynesia

Bronchiectasis, defined by an increase in bronchial caliber and thickening of the bronchial wall, is associated with recurrent respiratory infections, chronic cough and bronchorrhea, and a frequent progression to chronic respiratory failure. Investigator distinguish focal bronchiectasis usually resulting from a localized cause and diffuse bronchiectasis which the possible causes are multiple (immune deficiencies, genetic diseases, auto immune pathologies, aspergillosis broncho -allergic lung, sequelae of pulmonary infections).The etiological assessment is negative in 26 to 53% of cases, defining the idiopathic bronchiectasis. However, the discovery of an underlying cause can change the patient's management (up to 37% of cases).

Despite the lack of epidemiological data in French Polynesia, Australian and New Zealand studies found a high prevalence of bronchiectasis in Polynesians. Few clinical studies published in the early 1980s suggested a ciliary origin.

Due to its geographic characteristics, the Polynesian population constitutes an interesting ethnic group. Indeed, there is a low genetic mixing and the prevalence of certain genetic diseases like the syndrome of Alport or some hereditary retinal dystrophies are high. This type of population is very suitable for discovering new genes in human pathology.

Investigator decided to conduct an observational study to find an underlying genetic cause of bronchiectasis in Polynesians by performing a whole exome sequencing. Investigator chose to study index cases defined by an upset of symptoms during the childhood, a family history of idiopathic bronchiectasis, and/or a consanguinity. Investigator also want to study healthy first degree relatives, in order to be able to better identify the clinical significant of DNA variants and focus the analysis on those that may be pathogenic

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CH Polynesie Française

Papeete, French Polynesia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

*Patients

Inclusion criteria

  • Polynesian adult more than18 years
  • dilatation of idiopathic bronchi confirmed to thoracic CTscan
  • Negative etiological balance (including sweat test, research of Dyskinesia Ciliary Primitive and immunological check-up)
  • Appearance of symptoms in childhood, or family history of chronic bronchial disease, or notion of inbreeding
  • Signed consent
  • Affiliated with a social security system

Exclusion criteria

  • Refusal to participate in the study

*Relatives

  • First-degree healthy relatives
  • Polynesian adult more than 18 years
  • Signed consent
  • Affiliated with a social security system

Exclusion criteria

  • Refusal to participate in the study

Treatment and study plan

Blood Test

Genetic

Blood analysis

Primary outcomes

  1. identification of genetic mutation

    Time frame: Anytime in the period of 10 years

    New mutation in the coding region or mutation located outside the coding regions on the transcriptome

Secondary outcomes

  1. Clinical phenotype

    Time frame: Anytime in the period of 10 years

    Extra-respiratory history Bronchial colonizations Scannographic aspect

  2. scannographic description

    Time frame: Anytime in the period of 10 years

    Extra-respiratory history Bronchial colonizations Scannographic aspect

  3. Effect on the splicing of messenger RNA

    Time frame: Anytime in the period of 10 years

    correlation genotype/phenotype

  4. transcriptome of patients

    Time frame: Anytime in the period of 10 years

    correlation genotype/phenotype

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Intercommunal Creteil

Other

Registry information

Official study title

Etude génétique Des Dilatations Des Bronches Idiopathiques en Polynésie française

Important dates

Study start
2022
Primary completion
2022
Study completion
2024
First posted
Jun 5, 2020
Registry last updated
Aug 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.